News
Andelyn Bio & Amplo Biotech partner to manufacture novel gene therapies for diseases affecting the neuromuscular junction: Columbus, Ohio Saturday, August 23, 2025, 10:00 Hrs [IST ...
Norfolk, Virginia Saturday, August 23, 2025, 09:00 Hrs [IST] ...
BDCDA alerts traders in Karnataka on Novo Nordisk insulins & semiglutide injections’ pilferage in transit: Nandita ...
Parliamentary Panel asks DoP to put more robust monitoring system for JAKs in place: Gireesh Babu, New Delhi Saturday, August 23, 2025, 08:00 Hrs [IST] The Parliamentary Panel on ...
Odisha govt notifies OPDC to propel state as a pharma hub in eastern India: Peethaambaran Kunnathoor, Chennai Saturday, August 23, 2025, 08:00 Hrs [IST] The Government of Odisha h ...
Pharmexcil strengthens Indo-Dutch pharma, healthcare ties ahead of iPHEX 2025: Shardul Nautiyal, Mumbai Saturday, August 23, 2025, 08:00 Hrs [IST] In a concerted effort to deepen ...
ICMR invites institutes to join INTENT to strengthen India’s clinical research ecosystem: Shardul Nautiyal, Mumbai Saturday, August 23, 2025, 08:00 Hrs [IST] The Indian Council ...
Akeso enrolls first patient in pivotal phase III trial of cadonilimab for perioperative treatment of resectable gastric cancer: Hong Kong Friday, August 22, 2025, 18:00 Hrs [IST] ...
Generic pharmacy chain DavaIndia plans to more than double its retail stores: Our Bureau, New Delhi Friday, August 22, 2025, 17:40 Hrs [IST] DavaIndia, the private generic pharmac ...
Merakris gets USPTO notice of allowance for foundational patent supporting MTX-001 biologic drug platform: Research Triangle Park, North Carolina Friday, August 22, 2025, 17:00 Hr ...
IBA, Heidelberg Univ Hospital ink contract to install Proteus ONE compact proton therapy solution at University campus in Heidelberg: Louvain-La-Neuve, Belgium Friday, August 22, ...
US FDA grants orphan drug designation to Keros Therapeutics’ KER-065 to treat Duchenne muscular dystrophy: Lexington, Massachusetts Friday, August 22, 2025, 15:00 Hrs [IST] Kero ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results